POWERED BY MOMENTUM MEDIA
Link to hold 43% of PEXA IPO
The shareholding in the PEXA initial public offering by superannuation administrator Link Group has been finalised to be 42.8%, as the listing date remains 1 July, 2021.
The listing would go ahead as long as the IPO continued to satisfy Australian Securities Exchange (ASX) listing requirements.
At the conclusion of the IPO, Link Group would hold 42.8% of the equity in PEXA and receive approximately $180 million of net cash proceeds.
The cash proceeds would be applied against debt in the first instance with the aim of delivering a stronger and more flexible balance sheet for Link Group.
Vivek Bhatia, Link Group chief executive and managing director, said: “Link Group has retained a significant holding in EA while strengthening its own balance sheet with gearing expected to be at the bottom of our target leverage range of two to three times net debt/EBITDA.
“Link Group will review its various options and advise the market releasing our FY results on 26 August, 2021.”
Recommended for you
Australia’s second-largest super fund has confirmed it is expanding its presence in the UK following significant investment in the region.
A member of the super fund has approached ASIC to investigate potentially misleading or deceptive representations by UniSuper regarding the holdings of its sustainable portfolios.
The median growth fund delivered 1.9 per cent in March, adding to the “stunning” rally that has seen super funds gain 11 per cent since November.
Vanguard has affirmed its support for the current super performance test, emphasising the importance of keeping the process straightforward.
TOP PERFORMING FUNDS
ACS FIXED INT - AUSTRALIA/GLOBAL BOND
Fund name
3y(%)pa
1
Spire Oaktree Opportunities XI First Close USD
66.99 3 y p.a(%)
2
Hills International
63.66 3 y p.a(%)
3
Acadian Global Equity Long Short Class A
36.33 3 y p.a(%)
4
CFS FC Acadian Global Equity Long Short
35.96 3 y p.a(%)
5
DomaCom 4/27 Crombie Avenue Bundall QLD 4217 Australia
32.23 3 y p.a(%)
Add new comment